These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8410185)

  • 41. RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport.
    Fountaine TM; Wade-Martins R
    J Neurosci Res; 2007 Feb; 85(2):351-63. PubMed ID: 17131421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
    Giros B; el Mestikawy S; Godinot N; Zheng K; Han H; Yang-Feng T; Caron MG
    Mol Pharmacol; 1992 Sep; 42(3):383-90. PubMed ID: 1406597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract.
    Zhao G; Jiang ZH; Zheng XW; Zang SY; Guo LH
    Pharmacol Biochem Behav; 2008 Sep; 90(3):363-71. PubMed ID: 18485464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synaptophysin enhances the neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells.
    Chen CX; Huang SY; Zhang L; Liu YJ
    Neurobiol Dis; 2005 Aug; 19(3):419-26. PubMed ID: 16023584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
    Johnson EA; Wu EY; Rollema H; Booth RG; Trevor AJ; Castagnoli N
    Eur J Pharmacol; 1989 Jul; 166(1):65-74. PubMed ID: 2806366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP+) but not release of MPP+ in rat C6 glioma cells expressing human dopamine transporter.
    Cao BJ; Reith ME
    Br J Pharmacol; 2002 Dec; 137(8):1155-62. PubMed ID: 12466224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dopamine transporter. The cloned target site of parkinsonism-inducing toxins and of drugs of abuse.
    Pifl C; Giros B; Caron MG
    Adv Neurol; 1996; 69():235-8. PubMed ID: 8615133
    [No Abstract]   [Full Text] [Related]  

  • 48. Progressive alteration of neuronal dopamine transporter activity in a rat injured by an intranigral injection of MPP+.
    Barc S; Page G; Barrier L; Huguet F; Fauconneau B
    Brain Res; 2002 Jun; 941(1-2):72-81. PubMed ID: 12031549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents.
    Sundström E; Samuelsson EB
    Pharmacol Toxicol; 1997 Nov; 81(5):226-31. PubMed ID: 9396088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MPP(+)-induced mitochondrial dysfunction is potentiated by dopamine.
    Boada J; Cutillas B; Roig T; Bermúdez J; Ambrosio S
    Biochem Biophys Res Commun; 2000 Feb; 268(3):916-20. PubMed ID: 10679305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.
    Choi SJ; Panhelainen A; Schmitz Y; Larsen KE; Kanter E; Wu M; Sulzer D; Mosharov EV
    J Biol Chem; 2015 Mar; 290(11):6799-809. PubMed ID: 25596531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH; Mytilineou C
    Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells.
    Gélinas S; Martinoli MG
    J Neurosci Res; 2002 Oct; 70(1):90-6. PubMed ID: 12237867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 21-aminosteroids interact with the dopamine transporter to protect against 1-methyl-4-phenylpyridinium-induced neurotoxicity.
    Sanchez-Ramos JR; Song S; Mash DC; Weiner WJ
    J Neurochem; 1992 Jan; 58(1):328-34. PubMed ID: 1727440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
    Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1000-7. PubMed ID: 7932147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diethyldithiocarbamate and disulfiram inhibit MPP+ and dopamine uptake by striatal synaptosomes.
    Di Monte D; Irwin I; Kupsch A; Cooper S; DeLanney LE; Langston JW
    Eur J Pharmacol; 1989 Jul; 166(1):23-9. PubMed ID: 2553428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolism of [14C]MPTP in mouse and monkey implicates MPP+, and not bound metabolites, as the operative neurotoxin.
    Yang SC; Johannessen JN; Markey SP
    Chem Res Toxicol; 1988; 1(4):228-33. PubMed ID: 2979736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.
    Xie T; McCann UD; Kim S; Yuan J; Ricaurte GA
    J Neurosci; 2000 Oct; 20(20):7838-45. PubMed ID: 11027249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism.
    Kawai H; Makino Y; Hirobe M; Ohta S
    J Neurochem; 1998 Feb; 70(2):745-51. PubMed ID: 9453570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter.
    Liu Y; Peter D; Roghani A; Schuldiner S; Privé GG; Eisenberg D; Brecha N; Edwards RH
    Cell; 1992 Aug; 70(4):539-51. PubMed ID: 1505023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.